Honey on healing of foot ulcer in diabetic patients
Phase 2
Completed
- Conditions
- diabetic foot ulcer.Diabetic peripheral angiopathy(I79.2*)
- Registration Number
- IRCT201402207494N8
- Lead Sponsor
- Vice Chancellor for research Mazandaran University of Medical Sciences.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
ulcer diabetic type 2 and 3 ; absence of vascular disease
Exclusion criteria; rheumatoid arthritis, vasculitis, chemotherapy, immunosuppressive and steroid drugs drugs affecting the nerves and blood vessels, such as anticonvulsants and anti-arrhythmias
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diiabetic foot ulcer. Timepoint: Befor study and at the end of the first, second and third week after intervention. Method of measurement: Researcher made list.
- Secondary Outcome Measures
Name Time Method Gangrene or amputation. Timepoint: Every day until the end of the study. Method of measurement: ?Assesment and report by a specialist nurse.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie spring honey's effect on diabetic foot ulcer healing and peripheral angiopathy?
How does spring honey compare to standard-of-care treatments like recombinant growth factors for diabetic foot ulcers?
Which biomarkers (e.g., VEGF, HbA1c) predict response to spring honey in patients with diabetic peripheral angiopathy?
What are the safety profiles and adverse event management strategies for spring honey in diabetic wound healing?
Are there combination therapies involving spring honey and anti-inflammatory agents for RAS pathway-related diabetic foot ulcers?